Table 1.
Mean value (median value) | Range | |
---|---|---|
Age (years) | 65,5 (64) | 42–84 |
Gender (male/female) | ||
IPSS stage | 19/17 | |
1 | 45% | |
2 | 39% | |
3 | 16% | |
Bone marrow involvement | 46,7% (40%) | 5–100% |
Lymphadenopathy | 21% | |
Splenomegaly | 19% | |
Hepatomegaly | 9% | |
Extranodal sites | 3% | |
IgM (mg/dL) | 2777,2 (2500) | 138–7870 |
Hb (g/dL) | 10,9 (11,1) | 6–14,3 |
Platelets (×109/L) | 233,2 (234) | 60–472 |
WBC (×109/L) | 7,1 (6,7) | 2,1–16,8 |
B2M (mg/dL) | 4,1 (3,4) | 1,9–10,4 |
Abnormal (high) LDH | 27% |